Neuroprotective effect of modified Wu-Zi-Yan-Zong granule, a traditional Chinese herbal medicine, on CoCl2-induced PC12 cells
Graphical abstract
Introduction
Senile dementia (SD) is one of the most common nervous system diseases in aged humans around the world. Recent researches reveal that hypoxic/ischemic neurological damage induced by aging is an important risk factor and actively involved in the pathogenesis of SD (Rao and Howard, 1998, Martin et al., 2008). Along with aging, chronic cerebral hypoxia or ischemia usually induces progressive neuronal cells death and further leads to amnesia and memory deterioration. However, little progress has been made over the past decades in developing novel and effective agents for senile dementia and age-related cognitive impairment.
The use of herbal medicine for the treatment of neuronal disorders, especially for senile dementia, has a long history in China. In clinical practice of traditional Chinese medicine, herbal formulas are widely used for anti-dementia and proved to own fewer side effects than western medicine. Modified Wu-Zi-Yan-Zong granule (MWG) is a traditional Chinese medicine and has clinically proven a good therapeutic effect on its anti-dementia properties. MWG, consisting of six medicinal plants (Cuscuta chinensis Lam., Lycium barbarum L., Rubus chingii Hu., Schizandra chinensis (Turcz.) Baill., Plantago asiatica L. and Epimedium brevicornu Maxim.), derived from traditional Chinese kidney-reinforcing medicine Wu-Zi-Yan-Zong Formula which was firstly documented in ancient Chinese medical works “She Sheng Zhong Miao Fang” (Volume 11) by Shi-Che Zhang in 1550 AD, and also recorded in Chinese Pharmacopoeia (The Pharmacopoeia Commission of PRC, 2005). In traditional Chinese medicine (TCM) theory, it is hold that decrease of memory ability is closely related to senility and kidney deficiency. Therefore the anti-dementia effect of MWG originates directly from its original reinforcing kidney effect. Previous clinical double-blind, randomized controlled trial and magnetic resonance imaging studies indicate that MWG improves both the memory quotient and hippocampal volume of patients with mild cognitive impairment (Fu et al., 2006, Fu et al., 2007). However, the underlying mechanism of MWG on its neuroprotective effect has not been totally explored until now.
In the present study, we examined the neuroprotective effect of MWG water extract against CoCl2-induced neurotoxicity in PC12 cells, which is widely used in vitro model simulating neuronal damage and apoptosis under hypoxia/ischemia insults (Hou et al., 2003, Jung and Kim, 2004, Jung et al., 2008), so as to deeply understand the potential mechanism behind the neuroprotective and anti-dementia activity of MWG.
Section snippets
Plant material and preparation of the extract
In this study, all traditional Chinese herbs were purchased from Tong Ren Tang Chinese Medicine Co., Ltd. (Beijing, China) and carefully authenticated by Dr. Peng-Fei Tu (School of Pharmaceutical Science, Peking University, Beijing, China) according to the Chinese pharmacopoeia (The Pharmacopoeia Commission of PRC, 2005). For MWG water extract preparation, Cuscuta chinensis Lam. (200 g), Lycium barbarum L. (200 g), Rubus chingii Hu. (100 g), Schizandra chinensis (Turcz.) Baill. (25 g), Plantago
Protective effect of MWG extract on neurotoxicity of PC12 cells
In a preliminary experiment, CCK-8 assay data showed that MWG extract up to 400 μg/mL did not show any significant toxicity for 48 h (Fig. 1A). Moreover, approximately 62.5 ± 12.4% of PC12 cells survived a treatment with CoCl2 (250 μM) for 24 h, and cell viability increased to 96.29 ± 1.7% (at 400 μg/mL) when the cells were pretreated with MWG extract for 1 h (Fig. 1B). Therefore, the results demonstrate that MWG extract protects PC12 cells from CoCl2-induced cell death in a dose-dependent manner.
Protective effect of MWG extract on apoptosis of PC12 cells
The
Discussion
Previous clinical practice has shown that the MWG possesses good anti-dementia effects on elderly patients (Fu et al., 2006, Fu et al., 2007). Here, our results indicate that MWG possesses neuroprotective and anti-apoptotic properties under the hypoxic/ischemic conditions induced by CoCl2. MWG extract could scavenge ROS in a dose-dependent manner, which was interpreted as a result of its anti-lipid peroxidation properties in a previous clinical trial (Wang et al., 2004). Moreover, our data
Acknowledgements
This work was supported by the Korea Institute of Science and Technology institutional program (Grant Nos. 2Z03270 and 2Z03380, Republic of Korea), National Natural Science Funds of China (Grant Nos. 30973813 and 30672760, China) and Research Fund for the Doctoral Program of Ministry of Education (Grant No. 20070001707, China).
References (21)
- et al.
Role of poly (ADP-ribose) polymerase (PARP) cleavage in apoptosis
The Journal of Biological Chemistry
(1999) - et al.
Sequential activation of activator protein-1-related transcription factors and JNK protein kinases may contribute to apoptotic death induced by transient hypoxia in developing brain neurons
Brain Research, Molecular Brain Research
(1998) - et al.
Involvement of mitochondrial- and Fas-mediated dual mechanism in CoCl2-induced apoptosis of rat PC12 cells
Neuroscience Letters
(2004) - et al.
Estradiol protects PC12 cells against CoCl2-induced apoptosis
Brain Research Bulletin
(2008) - et al.
Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death
The Journal of Biological Chemistry
(1998) The Pharmacopoeia Commission of PRC, vol. 2
(2005)- et al.
Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation
Endocrinology
(2007) - et al.
Ischemic brain injury is mediated by the activation of poly (ADP-ribose) polymerase
Journal of Cerebral Blood Flow & Metabolism
(1997) - et al.
Effects of modified Wu-Zi-Yan-Zong granule on memory ability and volume of hippocampus measured by MRI in patients with mild cognitive impairment
Chinese Journal of Integrated Traditional and Western Medicine
(2006) - et al.
The effect of Jiawei Wu-Zi-Yan-Zong granule on memory ability and level of serum beta-amyloid of mild cognitive impairment patients
Chinese Journal of Gerontology
(2007)
Cited by (16)
Biological potential and therapeutic effectiveness of pteryxin in medicine. A viable alternative to current remedies for the treatment of human disorders
2024, Pharmacological Research - Modern Chinese MedicineTherapeutic role of columbianadin in human disorders: Medicinal importance, biological properties and analytical aspects
2023, Pharmacological Research - Modern Chinese MedicineCitation Excerpt :More than 500 types of crude drugs and 400 Traditional Chinese Medicines (TCM) have been listed in the Chinese Pharmacopoeia [34–38]. Chinese herbal medicines are getting attention due to their long historical applications and reliable therapeutic efficacy [39–44]. TCM has been used for thousands of years as foods and drugs to maintain good health of human beings [45–48].
Development of Chinese Herbal Health Products for the Prevention of Aging-Associated Diseases
2018, Natural Products and Drug Discovery: an Integrated ApproachModified Wu-Zi-Yan-Zong prescription, a traditional Chinese polyherbal formula, suppresses lipopolysaccharide-induced neuroinflammatory processes in rat astrocytes via NF-κB and JNK/p38 MAPK signaling pathways
2012, PhytomedicineCitation Excerpt :Recent studies suggest that some flavonoids in MWP can pass through the blood brain barrier (BBB) and protect neurons from Aβ-induced neuronal injury (Zeng et al. 2010a). In addition, MWP extracts also show neuroprotective effects against cobalt chloride (CoCl2)-induced hypoxic neuronal injury in PC12 pheochromocytoma cells (Zeng et al. 2010b). Although the neuroprotective effects of MWP have been widely reported, the effects of MWP on neuroinflammation in the central nervous system (CNS) are still not well understood.
Protective effect of Wuzi Yanzong recipe on testicular DNA oxidative damage in natural ageing rats
2018, Zhongguo Zhongyao ZazhiProtective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease
2017, Journal of Neuroinflammation